Chinese drugmaker Clover says vaccine prevents COVID-19 in large trial NewsBreak


Key Topics in this News Article:

News Snapshot:

Chinese drugmaker Clover Biopharmaceuticals said Wednesday its experimental coronavirus vaccine prevented COVID-19 in a large Phase 3 trial, reporting efficacy of 67% against disease of any severity and 85% against moderate-to-severe disease. Clover is preparing to seek conditional authorization with global regulatory agencies in the fourth quarter and is targeting...